Search results
What drug manufacturer Lonza plans to do with Genentech's soon-to-be-former Vacaville site - San...
The Business Journals· 5 days agoWhen Lonza AG closes its $1.2 billion acquisition of Genentech Inc.'s Vacaville biomanufacturing...
Novartis, Roche unit and others face Italy antitrust probe over eye drug
Reuters via Yahoo News· 3 days agoROME (Reuters) -Italy's antitrust regulator said on Thursday it had launched an investigation into...
ASCO24: Enhertu aims to replace Herceptin in first-line metastatic breast cancer
Pharmaceutical Technology via Yahoo Finance· 7 days agoThe trial aims to assess the safety and tumour response with Enhertu alone or in combination with ...
High Rate of Surgery in Patients With Crohn's Disease
Medscape· 6 days agoScientific data indicate that the chance of a patient with Crohn's disease undergoing intestinal...
ASMS 2024: MOBILion mass spectrometry platform in spotlight
Medical Device Network via Yahoo Finance· 2 days agoGenentech presented findings on MOBIE’s characterisation of a small molecule drug compound it said...
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations - Novartis...
Benzinga· 3 days agoItaly’s antitrust regulator has initiated an investigation into several pharmaceutical giants,...
Even during biotech down cycle, nearly two dozen Bay Area companies flock to major convention - San...
The Business Journals· 3 days agoWhen Moonwalk Biosciences Inc. CEO Alex Aravanis started his presentation at the BIO convention in...
Antitrust Investigation Targets Major Pharma Companies in Italy
PYMNTS.com· 3 days agoItaly’s antitrust agency, the Italian Competition Authority (AGCM), has launched an investigation...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 2 days agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 3 days agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.